|
|
||||||||




Departments of*
Microbiology and Immunology and
Pathology, University of Texas Medical Branch, Galveston, TX 77555
Severe acute respiratory syndrome (SARS) caused by a novel human coronavirus (CoV), designated SARS-CoV, is a highly contagious respiratory disease with the lungs as a major target. Although the exact mechanism of SARS-CoV pathogenesis remains unknown, an intense, ill-regulated local inflammatory response has been suggested as partially responsible for the devastating lung pathology. We investigated the interaction of SARS-CoV with human macrophages (M
) and dendritic cells (DC), two key innate immune cells of the host immune system, by focusing on their susceptibility to viral infection and subsequent responses (e.g., phenotypic maturation, T cell-priming activity, phagocytosis, and cytokine production). We found neither cell to be permissive for SARS-CoV replication. However, incubation of M
and DC with live, but not gamma irradiation-inactivated, viruses appeared to better sustain their viability. Also, exposure to infectious SARS-CoV led to the phenotypic and functional maturation of DC, with regard to MHC class II and costimulatory molecule expression, T cell-stimulatory capacity, and cytokine production, respectively. Cytokine production was also observed for M
, which were refractory to cell surface phenotypic changes. Strikingly, live SARS-CoV could further prime cell types to respond to a suboptimal dose of bacterial LPS (100 ng/ml), resulting in massive release of IL-6 and IL-12. However, the endocytic capacity (e.g., Ag capture) of M
was significantly compromised upon exposure to infectious SARS-CoV. This study is the first demonstration that although SARS-CoV does not productively infect human M
or DC, it appears to exert differential effects on M
and DC maturation and functions, which might contribute to SARS pathogenesis.
This article has been cited by other articles:
![]() |
N. Yoshikawa, T. Yoshikawa, T. Hill, C. Huang, D. M. Watts, S. Makino, G. Milligan, T. Chan, C. J. Peters, and C.-T. K. Tseng Differential Virological and Immunological Outcome of Severe Acute Respiratory Syndrome Coronavirus Infection in Susceptible and Resistant Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 J. Virol., June 1, 2009; 83(11): 5451 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, T. Hill, K. Li, C. J. Peters, and C.-T. K. Tseng Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells J. Virol., April 1, 2009; 83(7): 3039 - 3048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Netland, D. K. Meyerholz, S. Moore, M. Cassell, and S. Perlman Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 J. Virol., August 1, 2008; 82(15): 7264 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu and C. Korteweg Pathology and Pathogenesis of Severe Acute Respiratory Syndrome Am. J. Pathol., April 1, 2007; 170(4): 1136 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. K. Tseng, C. Huang, P. Newman, N. Wang, K. Narayanan, D. M. Watts, S. Makino, M. M. Packard, S. R. Zaki, T.-s. Chan, et al. Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor J. Virol., February 1, 2007; 81(3): 1162 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Spiegel, K. Schneider, F. Weber, M. Weidmann, and F. T. Hufert Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells J. Gen. Virol., July 1, 2006; 87(7): 1953 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ziegler, S. Matikainen, E. Ronkko, P. Osterlund, M. Sillanpaa, J. Siren, R. Fagerlund, M. Immonen, K. Melen, and I. Julkunen Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells J. Virol., November 1, 2005; 79(21): 13800 - 13805. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |